Paying users zone. Data is hidden behind: .
Get 1-month access to Gilead Sciences Inc. for $15.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Gilead Sciences Inc. pages available today for free:
Analysis of Debt
Total Debt (Carrying Amount)
Gilead Sciences Inc., balance sheet: debt
US$ in millions
Based on: 10-K (filing date: 2021-02-25), 10-K (filing date: 2020-02-25), 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27).
| Debt item | Description | The company |
|---|---|---|
| Total short-term and long-term debt (carrying amount) | Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. | Gilead Sciences Inc.’s total debt decreased from 2018 to 2019 but then increased from 2019 to 2020 exceeding 2018 level. |
Total Debt (Fair Value)
| Dec 31, 2020 | |
|---|---|
| Selected Financial Data (US$ in millions) | |
| Senior unsecured notes and term loan facility | |
| Liability related to future royalties | |
| Total short-term and long-term debt (fair value) | |
| Financial Ratio | |
| Debt, fair value to carrying amount ratio | |
Based on: 10-K (filing date: 2021-02-25).
Weighted-average Interest Rate on Debt
Weighted-average interest rate on debt:
| Interest rate | Debt amount1 | Interest rate × Debt amount | Weighted-average interest rate2 |
|---|---|---|---|
| Total | |||
Based on: 10-K (filing date: 2021-02-25).
1 US$ in millions
2 Weighted-average interest rate = 100 × ÷ =